Safety and diagnostic performance of endoscopic ultrasound-guided fine needle biopsy in pancreatic cystic and mixed lesions

Table 4 Follow-Up and outcomes, n (%)/mean ± SD

Variable	Total patients (n = 60)
Mean follow-up duration (months) from date of procedure to date of death or last visit	17.0 ± 14.3
Management
Follow up	13 (21.7)
Repeat EUS and diagnosis	6 (10.0)
Chemotherapy	23 (38.3)
Surgical	10 (16.7)
Drainage	1 (1.7)
Missing data	7 (11.6)
Concordance of EUS-FNB compared to surgical pathology for patients who had surgery	10/10 (100)
Death	14 (23.3)
Cause of death
Metastatic pancreatic cancer	11/14 (78.6)
Other death	2/14 (14.3)
Other cancers	1/14 (7.1)

EUS: Endoscopic ultrasound; FNB: Fine needle biopsy.